Multi Dozes Oral Dexamethasone Reduce Inflammatory Response and Complications in Total Joint Arthroplasty: A Prospective Randomized Control Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023839

Enrollment

Unknown

Registered

2019-06-14

Start date

2019-06-14

Completion date

Unknown

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip and knee joint disease

Interventions

Experiment Group:Perioperative Multi Dozes Oral Dexamethasone

Control Group:Perioperative Oral Placebo

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 85 years; Undertake total knee arthroplasty; Informed consent is available.

Exclusion criteria

Exclusion criteria: history of dexamethasone allergy.

Design outcomes

Primary

Measure	Time frame
Function outcomes;Complications;Inflammatory Response (CRP?IL-6);	—

Secondary

Measure	Time frame
Pain;Hospital Stay;Satisfaction Rate;	—

Countries

China

Contacts

Public ContactZongke Zhou

West China Hospital, Sichuan University

zongke@126.com+86 13207100126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026